A meta-analysis of cytokines in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biological Psychiatry

• Publication date

  2010-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.biopsych.2010.06.012PMID 20692646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in Atherosclerosis

  2012cited by this paper
• Efficacy of PPAR-agonist pioglitazone in mild Alzheimer disease

  2011cited by this paper
• Cardiorespiratory fitness and brain atrophy in early Alzheimer disease

  2010cited by this paper
• A PHASE 2 MULTIPLE ASCENDING DOSE TRIAL OF BAPINEUZUMAB IN MILD TO MODERATE ALZHEIMER DISEASE

  2010cited by this paper
• Genome-wide analysis of genetic loci associated with Alzheimer disease.

  2010cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Transport of interleukin‐1 across cerebromicrovascular endothelial cells

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up

  2009cited by this paper
• Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma.

  2009cited by this paper
• Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

  2009cited by this paper
• Peripheral Cytokines and Chemokines in Alzheimer’s Disease

  2009cited by this paper
• Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

  2009cited by this paper
• Aβ aggregation and possible implications in Alzheimer's disease pathogenesis

  2009cited by this paper
• Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.

  2009cited by this paper
• Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment

  2009cited by this paper
• Systemic inflammation and disease progression in Alzheimer disease

  2009cited by this paper
• Suppression of Amyloid Deposition Leads to Long-Term Reductions in Alzheimer's Pathologies in Tg2576 Mice

  2009cited by this paper
• Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9

  2009cited by this paper
• Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer’s disease patients

  2009cited by this paper
• Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.

  2009cited by this paper
• Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke.

  2009cited by this paper
• Koronyo-Hamaoui, M. et al. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J. Neurochem. 111, 1409-1424

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population.

  2009cited by this paper
• 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

  2009cited by this paper
• The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines.

  2009cited by this paper
• A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

  2009cited by this paper
• TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.

  2009cited by this paper
• Relationship between plasma inflammatory markers and plaque fibrous cap thickness determined by intravascular optical coherence tomography

  2009cited by this paper
• CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

  2009cited by this paper
• The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons

  2009cited by this paper
• Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease.

  2009cited by this paper
• Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

  2008cited by this paper
• Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.

  2008influential reference
• Multiplex Analysis of Cytokines in the Serum and Cerebrospinal Fluid of Patients With Alzheimer's Disease by Color-Coded Bead Technology

  2008influential reference
• Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.

  2008cited by this paper
• Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

  2008cited by this paper
• CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.

  2008cited by this paper
• Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.

  2008influential reference
• An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA

  2008cited by this paper
• Cytokines in Alzheimer's Disease and Vascular Dementia

  2008cited by this paper
• Meta-Regression in Stata

  2008cited by this paper
• Systemic immune aberrations in Alzheimer's disease patients.

  2008influential reference
• The Diagnostic Role of Serum Inflammatory and Soluble Proteins on Dementia Subtypes: Correlation with Cognitive and Functional Decline

  2008cited by this paper
• Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?

  2008cited by this paper
• Interleukin-18 produced by peripheral blood cells is increased in Alzheimer's disease and correlates with cognitive impairment.

  2008cited by this paper
• Inflammation and Alzheimer's disease: Possible role of periodontal diseases

  2008cited by this paper
• Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia.

  2008cited by this paper
• Cardiorespiratory fitness and brain atrophy in early Alzheimer disease

  2008cited by this paper
• Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.

  2008cited by this paper
• Metan: Fixed- and Random-Effects Meta-Analysis

  2008cited by this paper
• Pharmacologic cholinesterase inhibition improves survival in experimental sepsis*

  2008cited by this paper
• Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology

  2008cited by this paper
• Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.

  2008cited by this paper
• Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

  2007cited by this paper
• Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

  2007cited by this paper
• Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Authors' reply

  2007cited by this paper
• Vascular factors predict rate of progression in Alzheimer disease

  2007cited by this paper
• High interleukin‐6 plasma levels are associated with functional impairment in older patients with Vascular dementia

  2007cited by this paper
• Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.

  2007cited by this paper
• Systemic infections and inflammation affect chronic neurodegeneration

  2007cited by this paper
• Serum levels and genetic variation of TGF‐β1 are not associated with Alzheimer’s disease

  2007cited by this paper
• Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment

  2007influential reference
• Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.

  2007influential reference
• Increased production of inflammatory cytokines in mild cognitive impairment.

  2007cited by this paper
• Level and value of interleukin-18 after acute ischemic stroke.

  2007cited by this paper
• Potential biomarkers for dementia in Trinidad and Tobago.

  2007cited by this paper
• Elevated Serum C-Reactive Protein Concentration in Bosnian Patients with Probable Alzheimer's Disease

  2007cited by this paper
• Foxp3 in control of the regulatory T cell lineage

  2007cited by this paper
• Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.

  2007influential reference
• Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.

  2007cited by this paper
• Determinants of platelet activation in Alzheimer's disease.

  2007cited by this paper
• Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.

  2007cited by this paper
• Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.

  2006influential reference
• Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

  2006cited by this paper
• IL-15 Is Elevated in Cerebrospinal Fluid of Patients With Alzheimer’s Disease and Frontotemporal Dementia

  2006cited by this paper
• Interleukin‐18 and transforming growth factor‐beta 1 plasma levels in Alzheimer’s disease and vascular dementia

  2006influential reference
• Regulation of Th2 differentiation and Il4 locus accessibility.

  2006cited by this paper
• Change in circulating C-reactive protein is not associated with atorvastatin treatment in Alzheimer's disease

  2006cited by this paper
• Analysis of Serum of Patients With Alzheimer’s Disease for the Level of Advanced Glycation End Products

  2006influential reference
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease

  2006cited by this paper
• Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.

  2006cited by this paper
• Increased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patients

  2006cited by this paper
• Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage

  2006cited by this paper
• Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

  2006cited by this paper
• Monitoring tryptophan metabolism in chronic immune activation.

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

  2005cited by this paper
• Matrix Metalloproteinase-9, Its Tissue Inhibitor(TIMP)-1 and CRP in Alzheimer’s Disease

  2005cited by this paper
• Diminished Production of Proinflammatory Cytokines in Patients with Alzheimer’s Disease

  2005cited by this paper
• Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

  2005cited by this paper
• Neurobiology of Disease 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate-Amyloid-Induced Microglial Inflammatory Responses

  2005cited by this paper
• Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.

  2005cited by this paper
• Memantine for dementia.

  2005cited by this paper
• Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other Dementias

  2005cited by this paper
• Association between Dementia and Infectious Disease: Evidence from a Case-Control Study

  2005cited by this paper
• Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?

  2005cited by this paper
• Role of kynurenines in the central and peripheral nervous systems.

  2005cited by this paper

• Oleanolic Acid and Alzheimer’s Disease: Mechanistic Hypothesis of Therapeutic Potential

  2026cites this paper
• Intelectin-1 and systemic inflammation indices as potential biomarkers in alzheimer’s disease

  2026cites this paper
• Identification of plasma inflammatory biomarkers for Alzheimer's disease reveals IFN-γ as a regulator of ACSL1-mediated microglia phenotype.

  2026cites this paper
• A dive into the untapped potential of marine compounds in counteracting neurodegeneration.

  2026cites this paper
• Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic APPSwe/PS1∆E9 Mice

  2026cites this paper
• Electrical stimulation of the vagus nerve improves amyloid pathology in delirium superimposed on dementia

  2026cites this paper
• Inflammatory mechanisms underlying early Alzheimer's disease pathology: evidence from the aging rhesus macaque brain.

  2026cites this paper
• Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization study

  2026cites this paper
• JAK Inhibitors and Memory Impairment: Disproportionality Analyses in the WHO Global Pharmacovigilance Database, VigiBase

  2026cites this paper
• Innate Immune Tolerance Regulates Microglia Response to Aβ Oligomers

  2026cites this paper
• Systemic inflammation, delirium and clinical progression in mild-moderate Alzheimer disease.

  2026cites this paper
• Inflammatory markers associated with dementia: a systematic review and meta-analysis.

  2026cites this paper
• CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice

  2026cites this paper
• Overexpression of FoxO3a in the dentate gyrus alleviates CUS-induced anxiety- and depression-like behaviors and cognitive impairment.

  2026cites this paper
• Exploring the role of Transcranial magnetic stimulation in cognitive impairment and sarcopenia: a narrative review

  2025cites this paper
• Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis

  2025cites this paper
• Intranasal administration of Ganoderma lucidum-derived exosome-like nanovesicles ameliorates cognitive impairment by reducing inflammation in a mouse model of Alzheimer’s disease

  2025cites this paper
• Peripheral Inflammation and Insulin Resistance: Their Impact on Blood–Brain Barrier Integrity and Glia Activation in Alzheimer’s Disease

  2025cites this paper
• Neuronally‐Derived Extracellular Vesicles Transforming Growth Factor Beta‐1 Levels in Progressive Supranuclear Palsy

  2025cites this paper
• Cognitive Decline in Chronic Inflammatory Conditions: Exploring Links Between Systemic Inflammation and Neurodegeneration

  2025cites this paper
• Relationship Between Cognitive Ability and Phase Angle in Older Adults with Cardiovascular Disease: A Cross-Sectional Study

  2025cites this paper
• The role of plasma inflammatory markers in late-life depression and conversion to dementia: a 3-year follow-up study

  2025cites this paper
• Inflammatory Bridges: Interconnections Between Alzheimer’s Disease and Bone Health

  2025cites this paper
• Whole Transcriptome RNA-Seq Reveals Drivers of Pathological Dysfunction in a Transgenic Model of Alzheimer’s Disease

  2025cites this paper
• Cerebrospinal fluid levels of tumour necrosis factor-α and its receptors are not associated with disease progression in Alzheimer’s disease

  2025cites this paper
• Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions

  2025cites this paper
• Amyloid-β-regulated gene circuits for programmable Alzheimer’s disease therapy

  2025cites this paper
• Insights into the role of cerebrospinal fluid cytokines in Alzheimer's disease: A commentary on recent findings

  2025cites this paper
• Cytokines and immune biomarkers in neurodegeneration and cognitive function: A systematic review among individuals of African ancestry

  2025cites this paper
• Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease.

  2025cites this paper
• Integrating Bulk and Single-Cell Transcriptomic Data to Identify Ferroptosis-Associated Inflammatory Gene in Alzheimer’s Disease

  2025cites this paper
• Brain penetration of peripheral extracellular vesicles from Alzheimer's patients and induction of microglia activation

  2025cites this paper
• The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer's Disease, and mild cognitive impairment.

  2025cites this paper
• The Endothelial Cell-Related Genes EIF1 and HSPA1B Contribute to the Pathogenesis of Alzheimer’s Disease by Modulating Peripheral Immunoinflammatory Responses

  2025cites this paper
• The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization

  2025cites this paper
• Associations between white matter lesions, adiposity, and systemic inflammation in late adulthood: Results from the IGNITE study.

  2025cites this paper
• Peripheral inflammation in a Canadian cohort of neurodegenerative conditions: Occurrence, determinants, and impact

  2025cites this paper
• Evaluating Microglial Contributions to the Neurovascular Unit in Health and Neurodegeneration Using Human In Vitro Models

  2025cites this paper
• The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease

  2025cites this paper
• Imbalance of T cell subsets: a core event that mediates the progression of T2DM and its complications

  2025cites this paper
• Immune Profiling in Early Cognitive Disorders (IMPRINT) study protocol: a longitudinal cohort study exploring biomarkers of inflammation in early dementia with Lewy bodies and Alzheimer’s disease, as part of the Dementias Platform UK

  2025cites this paper
• Transcutaneous electrical stimulation enhances episodic memory encoding via a noradrenaline-attention network, with associated neuroinflammatory changes.

  2025cites this paper
• Association between plasma cytokine levels and multiple neuroimaging modalities in mild cognitive impairment

  2025influential citation
• The Role of Glial Cell Senescence in Alzheimer's Disease

  2025cites this paper
• Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death

  2025cites this paper
• Major Depressive Disorder in Long COVID and Exposure to Pro‐Inflammatory Cytokines During Infection by SARS‐CoV‐2

  2025cites this paper
• Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation

  2025cites this paper
• Shared Neuroinflammatory Mechanisms Across Dementia Types: An Integrative Review

  2025cites this paper
• The aging interactome: From cellular dysregulation to therapeutic frontiers in age-related diseases.

  2025cites this paper
• Depression as a risk factor for Alzheimer’s disease: A human post-mortem study

  2025cites this paper
• INTEGRATIVE SYSTEMS BIOLOGY AND MULTI-OMICS APPROACHES IN ALZHEIMER'S DISEASE: BRIDGING BIOMARKERS, NEUROINFLAMMATION, AND PRECISION MEDICINE

  2025cites this paper
• Impact of TNF inhibitors on inflammation-associated cognitive dysfunction in patients with rheumatoid arthritis: a prospective analysis

  2025cites this paper
• Key biomarkers in Alzheimer’s disease: Insights for diagnosis and treatment strategies

  2025cites this paper
• Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy

  2025cites this paper
• Exploration and validation of the immune-related genes signatures and potential molecular mechanisms shared between Alzheimer’s disease (AD) and Parkinson’s disease (PD)

  2025cites this paper
• Real-Time, Continuous Monitoring of Tissue Chips as an Emerging Opportunity for Biosensing

  2025cites this paper
• From genetic roots to recent advancements in gene therapy targeting amyloid beta in Alzheimer’s disease

  2025cites this paper
• Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease

  2025cites this paper
• Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery

  2025cites this paper
• Pro‐inflammatory/Anti‐Inflammatory Interleukin Imbalance in Iraqi Alzheimer's Patients: Implications for Post‐Conflict Environmental Exposures

  2025cites this paper
• Mendelian Randomization in Conjunction with WGCNA Was Employed to Investigate the Potential Role of the Liver-Brain Axis in the Pathogenesis of Hepatocellular Carcinoma and Alzheimer’s Disease

  2025cites this paper
• Non-Cognitive Symptoms in Alzheimer’s Disease and Their Likely Impact on Patient Outcomes. A Scoping Review

  2025cites this paper
• Association of Rheumatoid Arthritis With Progression of Cognitive Impairment and Risk of Mortality in People With Dementia

  2025cites this paper
• Circulating Biomarkers for the Early Diagnosis of Alzheimer’s Disease

  2025cites this paper
• Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a pQTL-based Mendelian randomization and colocalization analysis

  2025cites this paper
• Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease

  2025cites this paper
• Emerging anti-inflammatory nanosystems targeted to the brain.

  2025cites this paper
• Development of Zebrafish model for Iron Induced Neuroinflammation

  2025influential citation
• Structural characterization and in vitro bioactivity of Furcellaria lumbricalis polysaccharides: Implications for skin, immune, and gut health applications.

  2025cites this paper
• Vascular Dementia: From Pathophysiology to Therapeutic Frontiers

  2025cites this paper
• Biological determinants of blood-based biomarker levels in Alzheimer’s disease: role of nutrition, inflammation, and metabolic factors

  2025cites this paper
• Olfactory Dysfunction and Cognitive Decline: Are They Related?

  2025cites this paper
• Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Fatigue in Post‐COVID Syndrome: A Randomized, Single‐Blind, Sham‐Controlled Study

  2025cites this paper
• Utility of phase angle from bioelectrical impedance analysis as a disease-related clinical marker in people with dementia: A systematic review and meta-analysis.

  2025cites this paper
• Exploring potential targets and molecular mechanisms of traumatic brain injury exacerbated by Benzo(a)pyrene via network toxicology and molecular dynamics simulation

  2025cites this paper
• Sarcopenia and cognitive impairment: a multidimensional study of clinical associations, shared genetics, and causal links

  2025cites this paper
• Luteolin in Safflower Leaves Suppresses Microglial Inflammation Through FOXO3-Mediated Trem2 Transcription

  2025cites this paper
• Causal effects for neurodegenerative diseases on the risk of myocardial infarction: a two-sample Mendelian randomization study

  2024cites this paper
• The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease

  2024cites this paper
• Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer’s Disease

  2024cites this paper
• Sex differences in the relationship between depression and Alzheimer’s disease—mechanisms, genetics, and therapeutic opportunities

  2024cites this paper
• Retracted Article: The interaction between insulin resistance and Alzheimer’s disease: a review article

  2024cites this paper
• Inhibition of Amyloid-β (Aβ)-Induced Cognitive Impairment and Neuroinflammation in CHI3L1 Knockout Mice through Downregulation of ERK-PTX3 Pathway

  2024cites this paper
• Androgen deprivation therapy exacerbates Alzheimer’s-associated cognitive decline via increased brain immune cell infiltration

  2024cites this paper
• The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug

  2024cites this paper
• Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer’s disease

  2024cites this paper
• Disease-Modifying Antirheumatic Drugs and Dementia Prevention: A Systematic Review of Observational Evidence in Rheumatoid Arthritis

  2024cites this paper
• Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer’s Disease

  2024cites this paper
• Neuroprotective and anti‐inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies

  2024cites this paper
• The impact of astrocytic NF-κB on healthy and Alzheimer’s disease brains

  2024cites this paper
• Systemic inflammatory markers and their association with Alzheimer’s disease: A cross-sectional analysis

  2024cites this paper
• Causal associations of genetically predicted gut microbiota and blood metabolites with inflammatory states and risk of infections: a Mendelian randomization analysis

  2024cites this paper
• Enrichment of liver MAIT cells in a mouse model of Alzheimer's disease.

  2024cites this paper
• Study on multi-target effects of the novel HDAC6 inhibitor W5 on Aβ/Cu2+-induced Alzheimer's disease model of rats.

  2024cites this paper
• Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia: a systematic review with meta-analysis

  2024cites this paper
• Neuroinflammation in comorbid depression in Alzheimer's disease: A pilot study using post-mortem brain tissue

  2024cites this paper
• Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment

  2024cites this paper
• Using 6-CIT, P300 encephalography, and pro-inflammation assessments for screening age-related cognitive decline and exploring associated risk factors in Egyptian elderly

  2024cites this paper
• Microglial Transforming Growth Factor-β Signaling in Alzheimer’s Disease

  2024cites this paper
• Water contamination: A culprit of serum heavy metals concentration, oxidative stress and health risk among residents of a Nigerian crude oil-producing community

  2024cites this paper